Companies:
51,276
Total Market Cap:
148220020362366.84
Global Rank
#4543
Country Rank
#130
Market Cap
3.47 B
Price
111.14
Change (%)
0.91%
Volume
13,651
Ambu A/S's latest marketcap:
3.47 B
As of 11/19/2025, Ambu A/S's market capitalization has reached $3.47 B. According to our data, Ambu A/S is the 4543th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 3.47 B |
| Revenue (ttm) | 920.6 M |
| Net Income (ttm) | 92.87 M |
| Shares Out | 0 |
| EPS (ttm) | 0.35 |
| Forward PE | 33.24 |
| Ex-Dividend Date | 12/05/2024 |
| Earnings Date | 11/05/2025 |
Market Cap Chart
Data Updated: 11/19/2025
Ambu A/S's yearly market capitalization.
Ambu A/S has seen its market value grow from £746.56 M to £2.66 B since 2014, representing a total increase of 256.31% and an annual compound growth rate (CAGR) of 12.37%.
| Date | Market Cap(£) | Market Cap(USD) | Change (%) | Global Rank |
|---|---|---|---|---|
| 11/19/2025 | £2.66 B | $3.47 B | -12.95% | 4543 |
| 12/30/2024 | £3.08 B | $3.85 B | -5.53% | 3623 |
| 12/29/2023 | £3.26 B | $4.15 B | 20.96% | 3331 |
| 12/30/2022 | £2.7 B | $3.26 B | -45.56% | 3795 |
| 12/30/2021 | £4.95 B | $6.7 B | -37.51% | 2528 |
| 12/30/2020 | £7.93 B | $10.83 B | 152.92% | 1523 |
| 12/30/2019 | £3.13 B | $4.16 B | -32.01% | 2737 |
| 12/28/2018 | £4.61 B | $5.88 B | 42.49% | 1774 |
| 12/29/2017 | £3.23 B | $4.37 B | 111% | 2604 |
| 12/30/2016 | £1.53 B | $1.89 B | 56.11% | 4123 |
Company Profile
About Ambu A/S
Ambu A/S is a global medical technology company specializing in the development, production, and sale of medical devices for hospitals, clinics, and emergency services. Founded in 1937 and headquartered in Ballerup, Denmark, Ambu A/S delivers innovative solutions across multiple medical disciplines.
Product Offerings
- Anaesthesia & Patient Monitoring: Comprehensive solutions for anaesthesia and diagnostics.
- Endoscopy Products: Includes bronchoscopes, rhinolaryngoscopes, duodenoscopes, gastroscopes, cystoscopes, and displaying units.
- Neurology Products: EEG and EMG electrodes, EMG-guided injections, and intraoperative monitoring tools.
- Cardiology Products: Specialized devices for cardiovascular care.
- Airway Management & Anaesthesia: Bronchoscopes, video laryngoscopes, double/single lumen tubes, endobronchial blockers, laryngeal masks, and resuscitators.
- Emergency & Training Solutions: Extrication collars, resuscitators, video laryngoscopes, and training manikins.
Frequently Asked Questions
-
What is Ambu A/S's (LON-0MJF) current market cap?As of 11/19/2025, Ambu A/S (including the parent company, if applicable) has an estimated market capitalization of $3.47 B USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does Ambu A/S (LON-0MJF) rank globally by market cap?Ambu A/S global market capitalization ranking is approximately 4543 as of 11/19/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.